These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 15661572)
1. Study of daunorubicin cardiotoxicity prevention with pyridoxal isonicotinoyl hydrazone in rabbits. Simůnek T; Klimtová I; Kaplanová J; Sterba M; Mazurová Y; Adamcová M; Hrdina R; Gersl V; Ponka P Pharmacol Res; 2005 Mar; 51(3):223-31. PubMed ID: 15661572 [TBL] [Abstract][Full Text] [Related]
2. Pyridoxal isonicotinoyl hydrazone (PIH) and its analogs as protectants against anthracycline-induced cardiotoxicity. Simunek T; Sterba M; Popelova O; Kaiserova H; Potacova A; Adamcova M; Mazurova Y; Ponka P; Gersl V Hemoglobin; 2008; 32(1-2):207-15. PubMed ID: 18274998 [TBL] [Abstract][Full Text] [Related]
3. Cardioprotective effects of a novel iron chelator, pyridoxal 2-chlorobenzoyl hydrazone, in the rabbit model of daunorubicin-induced cardiotoxicity. Sterba M; Popelová O; Simunek T; Mazurová Y; Potácová A; Adamcová M; Kaiserová H; Ponka P; Gersl V J Pharmacol Exp Ther; 2006 Dec; 319(3):1336-47. PubMed ID: 17003229 [TBL] [Abstract][Full Text] [Related]
4. Iron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity: a study of salicylaldehyde isonicotinoyl hydrazone (SIH). Sterba M; Popelová O; Simůnek T; Mazurová Y; Potácová A; Adamcová M; Guncová I; Kaiserová H; Palicka V; Ponka P; Gersl V Toxicology; 2007 Jun; 235(3):150-66. PubMed ID: 17459556 [TBL] [Abstract][Full Text] [Related]
5. Rabbit model for in vivo study of anthracycline-induced heart failure and for the evaluation of protective agents. Simůnek T; Klimtová I; Kaplanová J; Mazurová Y; Adamcová M; Sterba M; Hrdina R; Gersl V Eur J Heart Fail; 2004 Jun; 6(4):377-87. PubMed ID: 15182761 [TBL] [Abstract][Full Text] [Related]
6. Cardiac troponin T following repeated administration of pyridoxal isonicotinoyl hydrazone in rabbits. Adamcová M; Machácková J; Gersl V; Pelouch V; Simůnek T; Klimtová I; Hrdina R; Ponka P Physiol Res; 2002; 51(5):443-8. PubMed ID: 12470196 [TBL] [Abstract][Full Text] [Related]
7. The effect of new lipophilic chelators on the activities of cytosolic reductases and P450 cytochromes involved in the metabolism of anthracycline antibiotics: studies in vitro. Schröterová L; Kaiserová H; Baliharová V; Velík J; Gersl V; Kvasnicková E Physiol Res; 2004; 53(6):683-91. PubMed ID: 15588138 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of ECG time intervals in a rabbit model of anthracycline-induced cardiomyopathy: a useful tool for assessment of cardioprotective agents. Potáčová A; Adamcová M; Čajnáková H; Hrbatová L; Sterba M; Popelová O; Šimůnek T; Ponka P; Gersl V Physiol Res; 2007; 56(2):251-254. PubMed ID: 17504005 [TBL] [Abstract][Full Text] [Related]
9. [Effects of new antineoplastic agents (dimethoxybenflurone and Oracin) on the cardiovascular system and other parameters in the rabbit in vivo]. Machácková J; Gersl V; Adamcová M; Mazurová Y; Hrdina R; Mĕlka M; Nobilis M Acta Medica (Hradec Kralove) Suppl; 2000; 43(2):119-38. PubMed ID: 11413675 [TBL] [Abstract][Full Text] [Related]
10. Cardiac troponin T as an indicator of reduced left ventricular contractility in experimental anthracycline-induced cardiomyopathy. Simůnek T; Klimtová I; Adamcová M; Gersl V; Hrdina R; Sterba M; Kaplanová J; Mazurová Y Cancer Chemother Pharmacol; 2003 Nov; 52(5):431-4. PubMed ID: 14618274 [TBL] [Abstract][Full Text] [Related]
11. Protein profiling in daunorubicin-induced cardiomyopathy. Adamcová M; Pelouch V; Gersl V; Kaplanová J; Mazurová Y; Simůnek T; Klimtová I; Hrdina R Gen Physiol Biophys; 2003 Sep; 22(3):411-9. PubMed ID: 14986890 [TBL] [Abstract][Full Text] [Related]
12. Early and delayed cardioprotective intervention with dexrazoxane each show different potential for prevention of chronic anthracycline cardiotoxicity in rabbits. Jirkovský E; Lenčová-Popelová O; Hroch M; Adamcová M; Mazurová Y; Vávrová J; Mičuda S; Šimůnek T; Geršl V; Štěrba M Toxicology; 2013 Sep; 311(3):191-204. PubMed ID: 23831762 [TBL] [Abstract][Full Text] [Related]
13. The effect of various chelating agents on the mobilization of iron from reticulocytes in the presence and absence of pyridoxal isonicotinoyl hydrazone. Ponka P; Grady RW; Wilczynska A; Schulman HM Biochim Biophys Acta; 1984 Dec; 802(3):477-89. PubMed ID: 6509088 [TBL] [Abstract][Full Text] [Related]
14. Noninvasive polygraphic cardiac changes in daunorubicin-induced cardiomyopathy in rabbits. Gersl V; Hrdina R Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1994; 37(2):49-55. PubMed ID: 7784798 [TBL] [Abstract][Full Text] [Related]
15. Mechanism of in vivo iron chelation by pyridoxal isonicotinoyl hydrazone and other imino derivatives of pyridoxal. Hershko C; Avramovici-Grisaru S; Link G; Gelfand L; Sarel S J Lab Clin Med; 1981 Jul; 98(1):99-108. PubMed ID: 7252329 [TBL] [Abstract][Full Text] [Related]
16. Pyridoxal isonicotinoyl hydrazone (PIH): a promising new iron chelator. Webb J; Vitolo ML Birth Defects Orig Artic Ser; 1988; 23(5B):63-70. PubMed ID: 3291971 [No Abstract] [Full Text] [Related]
17. Comparative study of chronic toxic effects of daunorubicin and doxorubicin in rabbits. Klimtová I; Simůnek T; Mazurová Y; Hrdina R; Gersl V; Adamcová M Hum Exp Toxicol; 2002 Dec; 21(12):649-57. PubMed ID: 12540035 [TBL] [Abstract][Full Text] [Related]
18. Investigation of the stability of aromatic hydrazones in plasma and related biological material. Kovaríková P; Mrkvicková Z; Klimes J J Pharm Biomed Anal; 2008 Jun; 47(2):360-70. PubMed ID: 18294799 [TBL] [Abstract][Full Text] [Related]
19. Deferiprone does not protect against chronic anthracycline cardiotoxicity in vivo. Popelová O; Sterba M; Simůnek T; Mazurová Y; Guncová I; Hroch M; Adamcová M; Gersl V J Pharmacol Exp Ther; 2008 Jul; 326(1):259-69. PubMed ID: 18434588 [TBL] [Abstract][Full Text] [Related]
20. [Plasma levels of troponin T in rabbits after administration of new antineoplastic agents (Oracin and Dimefluron) and daunorubicin]. Adamcová M; Machácková J; Gersl V; Hrdina R; Mazurová Y; Mĕlka M; Nobilis M Acta Medica (Hradec Kralove) Suppl; 2001; 44(1):3-8. PubMed ID: 11892362 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]